A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 352 participants.
Also called NCT07839585
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 352 participants
- Sponsor
- Registry
-
NCT07839585 -
2025-524634-25-00 -
U1111-1331-4324
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07839585. Randomized; quadruple masking; primary purpose treatment. Start 2026-11-26 (anticipated); primary completion 2030-01-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041)
- Acronym
- CHORUS
- Condition
- Pulmonary Hypertension
- Intervention (Biological)
- Sotatercept
- Intervention (Biological)
- Placebo
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct07839585- Content hash
7899206fb3a4f5d0235d23f3371f02df8dc070277da5c147dc58a24ee2f78470